Journal article
Hypocalcemia associated with estrogen therapy for metastatic adenocarcinoma of the prostate
The Journal of urology, Vol.140(5), pp.1025-1027
11/1988
DOI: 10.1016/S0022-5347(17)41918-5
PMID: 3172354
Abstract
We report 2 cases of true hypocalcemia (not caused by decreased binding proteins) associated with metastatic prostate cancer and review previously reported cases. Hypocalcemia is a common but frequently unrecognized complication of prostatic cancer. Estrogen therapy often is associated with the hypocalcemia, which may be asymptomatic. The hypocalcemia is always associated with osteoblastic metastases and usually it is associated with increased serum alkaline phosphatase activity, acid phosphatase activity and serum parathyroid hormone concentration. Serum concentrations of magnesium, phosphorus and vitamin D frequently are decreased. Patients are in a positive calcium balance. The osteoblastic metastases seem to act as a calcium sink, creating a "hungry tumor phenomenon". The role of estrogens may be to stop the resorption of normal bone resulting in lower serum calcium concentrations.
Details
- Title: Subtitle
- Hypocalcemia associated with estrogen therapy for metastatic adenocarcinoma of the prostate
- Creators
- S A Vogelgesang - Research Service, Sioux Falls Veterans Administration Hospital, South DakotaJ M McMillin
- Resource Type
- Journal article
- Publication Details
- The Journal of urology, Vol.140(5), pp.1025-1027
- DOI
- 10.1016/S0022-5347(17)41918-5
- PMID
- 3172354
- ISSN
- 0022-5347
- eISSN
- 1527-3792
- Language
- English
- Date published
- 11/1988
- Academic Unit
- Immunology; Internal Medicine; Ophthalmology and Visual Sciences
- Record Identifier
- 9984094745102771
Metrics
11 Record Views